Business
2 blue chip ASX 200 shares that could be strong buys
If you’re aiming to build a balanced portfolio, having a few blue chip ASX shares in there could be a smart move.
But which blue chip ASX 200 shares should you buy? Two that are highly rated are listed below:
The first blue chip ASX 200 share to look at is biotechnology giant CSL.
CSL has a focus on rare and serious diseases through its CSL Behring business and influenza vaccines through its Seqirus business.
CSL Behring has a wide range of innovative therapies. These are used to treat immunodeficiencies, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency, and neurological disorders. Whereas Seqirus has a broad range of flu products meeting the needs of different populations around the world.
While…
-
Noosa News22 hours agoDrivers call out bad manners and most hated acts on Queensland roads
-
Business23 hours agoHow to build a $250,000 passive income portfolio starting from zero
-
Noosa News24 hours agoBrisbane Lions looking for rookie Levi Ashcroft to step up against Gold Coast in absence of Lachie Neale
-
Noosa News22 hours agoCoochin Fields developer asked to explain shortfalls in tourist park proposal